ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension

Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung 2024-10, Vol.202 (5), p.753-755
Hauptverfasser: Ahmed, Hosam F., Morales, David L. S., Hayes, Don
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 755
container_issue 5
container_start_page 753
container_title Lung
container_volume 202
creator Ahmed, Hosam F.
Morales, David L. S.
Hayes, Don
description Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using the UNOS Registry, we investigated if ECMO at the time of transplant impacts post-transplant survival in children with IPAH. A total of 74 LTx recipients while on ECMO at the time of transplant were identified (IPAH: N = 12). Children with IPAH who underwent LTx while on ECMO had shown comparable survival rates to those who were on ECMO for other conditions. This analysis provides encouraging results, supporting the potential expansion of LTx for this patient population. Given the low number of children undergoing LTx, we think there should be a consensus document to provide better guidance for referring and selecting the high-risk pediatric population with IPAH on ECMO for lung transplant.
doi_str_mv 10.1007/s00408-024-00703-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050177064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3110366958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-151bddbc449576d1f31949be9f4626f9002b95fbbbe570e2e1dc1c8b74b048a13</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EgvLxBxiQJRaWwF3sOMkIVaGVimCAhcWKE6d1lTrBToT67zGUD4mBybbu8Xt3DyGnCJcIkF55AA5ZBDGPwhNYxHfICDmLI0wT2CUjYByjOEAH5ND7FQCmApN9csAykSMiG5GXyfj-gd44Uy007Vs6H-yCPrnC-q4pbE-NpeOlaSqnLX0z_ZLOKtN2Rb80JX0cmnVrC7eh167XzhQNnW46He7Wm9Yek726aLw--TqPyPPt5Gk8jeYPd7Px9TwqWSz6CBNUVaVKzvMkFRXWDHOeK53XXMSizgFilSe1UkonKehYY1VimamUK-BZgeyIXGxzO9e-Dtr3cm18qZswv24HLxkkYfEUBA_o-R901Q7OhukkQwQmRJ5kgYq3VOla752uZefMOuwpEeSHebk1L4N5-WlefkSffUUPaq2rny_fqgPAtoAPJbvQ7rf3P7HvbySNRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110366958</pqid></control><display><type>article</type><title>ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ahmed, Hosam F. ; Morales, David L. S. ; Hayes, Don</creator><creatorcontrib>Ahmed, Hosam F. ; Morales, David L. S. ; Hayes, Don</creatorcontrib><description>Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using the UNOS Registry, we investigated if ECMO at the time of transplant impacts post-transplant survival in children with IPAH. A total of 74 LTx recipients while on ECMO at the time of transplant were identified (IPAH: N = 12). Children with IPAH who underwent LTx while on ECMO had shown comparable survival rates to those who were on ECMO for other conditions. This analysis provides encouraging results, supporting the potential expansion of LTx for this patient population. Given the low number of children undergoing LTx, we think there should be a consensus document to provide better guidance for referring and selecting the high-risk pediatric population with IPAH on ECMO for lung transplant.</description><identifier>ISSN: 0341-2040</identifier><identifier>ISSN: 1432-1750</identifier><identifier>EISSN: 1432-1750</identifier><identifier>DOI: 10.1007/s00408-024-00703-4</identifier><identifier>PMID: 38691113</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adolescent ; Child ; Child, Preschool ; Children ; Correspondence ; Extracorporeal Membrane Oxygenation ; Familial Primary Pulmonary Hypertension - physiopathology ; Familial Primary Pulmonary Hypertension - surgery ; Female ; Humans ; Hypertension ; Infant ; Lung Transplantation ; Lung transplants ; Lungs ; Male ; Medicine ; Medicine &amp; Public Health ; Pediatrics ; Pneumology/Respiratory System ; Pulmonary hypertension ; Registries ; Retrospective Studies ; Survival ; Survival Rate ; Treatment Outcome</subject><ispartof>Lung, 2024-10, Vol.202 (5), p.753-755</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-151bddbc449576d1f31949be9f4626f9002b95fbbbe570e2e1dc1c8b74b048a13</cites><orcidid>0000-0002-7512-1777 ; 0000-0002-6734-6052 ; 0000-0001-8151-7391</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00408-024-00703-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00408-024-00703-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38691113$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Hosam F.</creatorcontrib><creatorcontrib>Morales, David L. S.</creatorcontrib><creatorcontrib>Hayes, Don</creatorcontrib><title>ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension</title><title>Lung</title><addtitle>Lung</addtitle><addtitle>Lung</addtitle><description>Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using the UNOS Registry, we investigated if ECMO at the time of transplant impacts post-transplant survival in children with IPAH. A total of 74 LTx recipients while on ECMO at the time of transplant were identified (IPAH: N = 12). Children with IPAH who underwent LTx while on ECMO had shown comparable survival rates to those who were on ECMO for other conditions. This analysis provides encouraging results, supporting the potential expansion of LTx for this patient population. Given the low number of children undergoing LTx, we think there should be a consensus document to provide better guidance for referring and selecting the high-risk pediatric population with IPAH on ECMO for lung transplant.</description><subject>Adolescent</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Correspondence</subject><subject>Extracorporeal Membrane Oxygenation</subject><subject>Familial Primary Pulmonary Hypertension - physiopathology</subject><subject>Familial Primary Pulmonary Hypertension - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Infant</subject><subject>Lung Transplantation</subject><subject>Lung transplants</subject><subject>Lungs</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pediatrics</subject><subject>Pneumology/Respiratory System</subject><subject>Pulmonary hypertension</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Survival</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0341-2040</issn><issn>1432-1750</issn><issn>1432-1750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EgvLxBxiQJRaWwF3sOMkIVaGVimCAhcWKE6d1lTrBToT67zGUD4mBybbu8Xt3DyGnCJcIkF55AA5ZBDGPwhNYxHfICDmLI0wT2CUjYByjOEAH5ND7FQCmApN9csAykSMiG5GXyfj-gd44Uy007Vs6H-yCPrnC-q4pbE-NpeOlaSqnLX0z_ZLOKtN2Rb80JX0cmnVrC7eh167XzhQNnW46He7Wm9Yek726aLw--TqPyPPt5Gk8jeYPd7Px9TwqWSz6CBNUVaVKzvMkFRXWDHOeK53XXMSizgFilSe1UkonKehYY1VimamUK-BZgeyIXGxzO9e-Dtr3cm18qZswv24HLxkkYfEUBA_o-R901Q7OhukkQwQmRJ5kgYq3VOla752uZefMOuwpEeSHebk1L4N5-WlefkSffUUPaq2rny_fqgPAtoAPJbvQ7rf3P7HvbySNRQ</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Ahmed, Hosam F.</creator><creator>Morales, David L. S.</creator><creator>Hayes, Don</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7512-1777</orcidid><orcidid>https://orcid.org/0000-0002-6734-6052</orcidid><orcidid>https://orcid.org/0000-0001-8151-7391</orcidid></search><sort><creationdate>20241001</creationdate><title>ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension</title><author>Ahmed, Hosam F. ; Morales, David L. S. ; Hayes, Don</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-151bddbc449576d1f31949be9f4626f9002b95fbbbe570e2e1dc1c8b74b048a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Correspondence</topic><topic>Extracorporeal Membrane Oxygenation</topic><topic>Familial Primary Pulmonary Hypertension - physiopathology</topic><topic>Familial Primary Pulmonary Hypertension - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Infant</topic><topic>Lung Transplantation</topic><topic>Lung transplants</topic><topic>Lungs</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pediatrics</topic><topic>Pneumology/Respiratory System</topic><topic>Pulmonary hypertension</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Survival</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Hosam F.</creatorcontrib><creatorcontrib>Morales, David L. S.</creatorcontrib><creatorcontrib>Hayes, Don</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Lung</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Hosam F.</au><au>Morales, David L. S.</au><au>Hayes, Don</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension</atitle><jtitle>Lung</jtitle><stitle>Lung</stitle><addtitle>Lung</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>202</volume><issue>5</issue><spage>753</spage><epage>755</epage><pages>753-755</pages><issn>0341-2040</issn><issn>1432-1750</issn><eissn>1432-1750</eissn><abstract>Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using the UNOS Registry, we investigated if ECMO at the time of transplant impacts post-transplant survival in children with IPAH. A total of 74 LTx recipients while on ECMO at the time of transplant were identified (IPAH: N = 12). Children with IPAH who underwent LTx while on ECMO had shown comparable survival rates to those who were on ECMO for other conditions. This analysis provides encouraging results, supporting the potential expansion of LTx for this patient population. Given the low number of children undergoing LTx, we think there should be a consensus document to provide better guidance for referring and selecting the high-risk pediatric population with IPAH on ECMO for lung transplant.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38691113</pmid><doi>10.1007/s00408-024-00703-4</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7512-1777</orcidid><orcidid>https://orcid.org/0000-0002-6734-6052</orcidid><orcidid>https://orcid.org/0000-0001-8151-7391</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0341-2040
ispartof Lung, 2024-10, Vol.202 (5), p.753-755
issn 0341-2040
1432-1750
1432-1750
language eng
recordid cdi_proquest_miscellaneous_3050177064
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Child
Child, Preschool
Children
Correspondence
Extracorporeal Membrane Oxygenation
Familial Primary Pulmonary Hypertension - physiopathology
Familial Primary Pulmonary Hypertension - surgery
Female
Humans
Hypertension
Infant
Lung Transplantation
Lung transplants
Lungs
Male
Medicine
Medicine & Public Health
Pediatrics
Pneumology/Respiratory System
Pulmonary hypertension
Registries
Retrospective Studies
Survival
Survival Rate
Treatment Outcome
title ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A53%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ECMO%20Bridge%20to%20Lung%20Transplant%20in%20Children%20with%20Idiopathic%20Pulmonary%20Arterial%20Hypertension&rft.jtitle=Lung&rft.au=Ahmed,%20Hosam%20F.&rft.date=2024-10-01&rft.volume=202&rft.issue=5&rft.spage=753&rft.epage=755&rft.pages=753-755&rft.issn=0341-2040&rft.eissn=1432-1750&rft_id=info:doi/10.1007/s00408-024-00703-4&rft_dat=%3Cproquest_cross%3E3110366958%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3110366958&rft_id=info:pmid/38691113&rfr_iscdi=true